Treatment results and prognostic factors in locally advanced hypopharyngeal cancer

Acta Oto-Laryngologica

Volumn 128, Issue 1, 2008, Pages 103-109

  Lee, Moon Sing ^a   Ho, Hsu Chueh ^a   Hsiao, Shih Hsuan ^a   Hwang, Juen Haur ^a   Lee, Ching Chih ^a   Hung, Shih Kai ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b St Martin De Porres Hospital   (Taiwan)

Author keywords

Concurrent chemoradiation; Hypopharyngeal carcinoma; Surgery; Weekly cisplatin

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; EAR NOSE THROAT SURGERY; ESOPHAGUS RESECTION; FEMALE; HUMAN; HYPOPHARYNX CANCER; INCIDENCE; LARYNGECTOMY; LARYNX; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; HYPOPHARYNGEAL NEOPLASMS; HYPOPHARYNX; KAPLAN-MEIERS ESTIMATE; LARYNGECTOMY; MALE; MIDDLE AGED; NEOPLASM STAGING; PHARYNGECTOMY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 37549022296     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480701387116     Document Type: Article

References (20)

1. Elias MM, Hilgers FJ, Keus RB, Gregor RT, Hart AA, Balm AJ. Carcinoma of the pyriform sinus: a retrospective analysis of treatment results over a 20-year period. Clin Otolaryngol Allied Sci 1995;20:249-53.
2. Pingree TF, Davis RK, Reichman O, Derrick L. Treatment of hypopharyngeal carcinoma: a 10-year review of 1,362 cases. Laryngoscope 1987;97(8 Pt 1):901-4.
3. Wahlberg PC, Andersson KE, Biorklund AT, Moller TR. Carcinoma of the hypopharynx: analysis of incidence and survival in Sweden over a 30-year period. Head Neck 1998;20:714-9.
4. Frank JL, Garb JL, Kay S, McClish DK, Bethke KP, Lind DS, et al. Postoperative radiotherapy improves survival in squamous cell carcinoma of the hypopharynx. Am J Surg 1994;168:476-80.
5. Kraus DH, Zelefsky MJ, Brock HA, Huo J, Harrison LB, Shah JP. Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx. Otolaryngol Head Neck Surg 1997;116(6 Pt 1):637-41.
6. Axon PR, Woolford TJ, Hargreaves SP, Yates P, Birzgalis AR, Farrington WT. A comparison of surgery and radiotherapy in the management of post-cricoid carcinoma. Clin Otolaryngol Allied Sci 1997;22:370-4.
7. Shirinian MH, Weber RS, Lippman SM, Dimery IW, Earley CL, Garden AS, et al. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience. Head Neck 1994;16:39-44.
8. Robbins KT. The evolving role of combined modality therapy in head and neck cancer. Arch Otolaryngol Head Neck Surg 2000;126:265-9.
9. Samant S, Kumar P, Wan J, Hanchett C, Vieira F, Murry T, et al. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function. Head Neck 1999;21:595-601.
10. Zelefsky MJ, Kraus DH, Pfister DG, Raben A, Shah JP, Strong EW, et al. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck 1996;18:405-11.
11. Forastiere AA. Induction and adjuvant chemotherapy for head and neck cancer: future perspectives. Acta Otorhinolaryngol Belg 1999;53:277-80.
12. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. AJCC cancer staging manual, 6th edn. New York: Springer-Verlag; 2002. p. 33-45.
13. DCTD, NCI, NIH, DHHS. Cancer therapy evaluation program common toxicity criteria, version 2.0, 1999:1-32.
14. Kaplan E, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958;53:457-81.
15. Mantle N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 1966;5:163-70.
16. Adelstein DJ, Saxton JP, Lavertu P, Tuason L, Wood BG, Wanamaker JR, et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 1997;19:567-75.
17. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081-6.
18. Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, et al. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol 2004;22:3061-9.
19. Hsu LP, Chen PR. Distant metastases of head and neck squamous cell carcinomas - experience from eastern Taiwan. Tzu Chi Med J 2005;17:99-104.
20. Kotwall C, Sako K, Razack MS, Rao U, Bakamjian V, Shedd DP. Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg 1987;154:439-42.